Dual-Pathway Antithrombotic Therapy in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention in Stable Coronary Artery Disease: A Single-Center, Single-Operator, Retrospective Cohort Study

MLA

Martin Danzer, et al. “Dual-Pathway Antithrombotic Therapy in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention in Stable Coronary Artery Disease: A Single-Center, Single-Operator, Retrospective Cohort Study.” Frontiers in Medicine, vol. 7, Sept. 2020. EBSCOhost, https://doi.org/10.3389/fmed.2020.00414.

APA

Martin Danzer, Daniel Duerschmied, Marcus Hortmann, Christoph Bode, Martin Moser, Christoph B. Olivier, & Lukas Andreas Heger. (2020). Dual-Pathway Antithrombotic Therapy in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention in Stable Coronary Artery Disease: A Single-Center, Single-Operator, Retrospective Cohort Study. Frontiers in Medicine, 7. https://doi.org/10.3389/fmed.2020.00414

Chicago

Martin Danzer, Daniel Duerschmied, Marcus Hortmann, Christoph Bode, Martin Moser, Christoph B. Olivier, and Lukas Andreas Heger. 2020. “Dual-Pathway Antithrombotic Therapy in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention in Stable Coronary Artery Disease: A Single-Center, Single-Operator, Retrospective Cohort Study.” Frontiers in Medicine 7 (September). doi:10.3389/fmed.2020.00414.